Biomedical Engineering Reference
In-Depth Information
dioxide laser ablation- a phase III, prospective, randomized, bicentric,
double-blind study. Dermatol Surg 2009; 35: 757-64.
241. Yoo KH, Kim BJ, Kim MN. Enhanced effi cacy of photodynamic therapy
with methyl-5-aminolevulinic acid in recalcitrant periungual warts after
ablative carbon dioxide fractional laser: a pilot study. Dermatol Surg
2009; 35: 1927-32.
242. Stringer MR, Collins P, Robinson DJ, et al. The accumulation of protopor-
phyrin IX in plaque psoriasis after topical application of 5-aminolaevulinic
acid indicates a potential for superfi cial photodynamic therapy. J Invest
Dermatol 1996; 107: 76-81.
243. Beattie PE, Dawe RS, Ferguson J, Ibbotson SH. Lack of effi cacy and toler-
ability of topical PDT for psoriasis in comparison with narrowband
UVB phototherapy. Clin Exp Dermatol 2004; 29: 560-2.
244. Schleyer V, Radakovic-Fijan S, Kerrer S, et al. Disappointing results and
low tolerability of photodynamic therapy with topical 5-aminolaevulinic
acid in psoriasis. A randomized, double-blind phase I⁄II study. J Eur Acad
Dermatol Venereol 2006; 20: 823-8.
245. Bissonnette R, Zeng H, McLean DI, et al. Oral aminolevulinic acid
induced protoporphyrin IX fl uorescence in psoriatic plaques and
peripheral blood cells. Photochem Photobiol 2001; 74: 339-45.
246. Edström DW, Porwit A, Ros AM. Photodynamic therapy with topical
5-aminolevulinic acid for mycosis fungoides: clinical and histological
response. Acta Derm Venereol (Stockh) 2001; 81: 184-8.
247. Zane C, Venturini M, Sala R, Calzavara-Pinton P. Photodynamic therapy
with methyl aminolevulinate as a valuable treatment option for unile-
sional cutaneous T-cell lymphoma. Photodermatol Photoimmunol
Photomed 2006; 22: 254-8.
248. Shieh S, Dee AS, Cheney RT, et al. Photodynamic therapy for the
treatment of extramammary Paget's disease. Br J Dermatol 2002; 146:
1000-5.
249. Housel JP, Izikson L, Zeitouni NC. Noninvasive extramammary Paget's
disease treated with photodynamic therapy: case series from the Roswell
Park Cancer Institute. Dermatol Surg 2010; 36: 1718-24.
250. Hayami J, Okamoto H, Sugihara A, Horio T. Immunosuppressive effects
of photodynamic therapy by topical aminolevulinic acid. J Dermatol
2007; 34: 320-7.
251. Karrer S, Bosserhoff AK, Weiderer P, Landthaler M, Szeimies RM.
Keratinocyte-derived cytokines after photodynamic therapy and their
paracrine induction of matrix metalloproteinases in fi broblasts. Br J
Dermatol 2004; 151: 776-83.
252. Karrer S, Szeimies RM. Photodynamic therapy: non-oncologic indica-
tions. Hautarzt 2007; 58: 585-96.
253. Karrer S, Abels C, Landthaler M, Szeimies RM. Topical photody-
namic therapy for localized scleroderma. Acta Derm Venereol 2000;
80: 26-7.
254. Hillemanns P, Untch M, Prove F, et al. Photodynamic therapy of vulvar
lichen sclerosus with 5-aminolevulinic acid. Obstet Gynecol 1999;
93: 71-4.
255. Schweiger ES, Riddle CC, Aires DJ. Treatment of hidradenitis suppura-
tiva by photodynamic therapy with aminolevulinic acid: preliminary
results. J Drugs Dermatol 2011; 10: 381-6.
256. Karrer S, Abels C, Wimmershoff MB, et al. Successful treatment of cuta-
neous sarcoidosis using topical photodynamic therapy. Arch Dermatol
2002; 138: 581-4.
257. Heidenheim M, Jemec GBE. Successful treatment of necrobiosis
lipoidica diabeticorum with photodynamic therapy. Arch Dermatol
2006; 142: 1548-50.
258. Parera E, Gallardo F, Toll A, et al. Infl ammatory linear verrucous epider-
mal nevus successfully treated with methyl-aminolevulinate photody-
namic therapy. Dermatol Surg 2010; 36: 253-6.
259. Enk CD, Fritsch C, Jonas F, et al. Treatment of cutaneous leishmaniasis
with photodynamic therapy. Arch Dermatol 2003; 139: 432-4.
260. Asilian A, Davami M. Comparison between the effi cacy of photody-
namic therapy and topical paromomycin in the treatment of Old World
cutaneous leishmaniasis: a placebo-controlled,randomized clinical trial.
Clin Exp Dermatol 2006; 31: 634-7.
261. Gold MH, Boring MM, Bridges TM, Bradshaw VL. The successful use
of ALA-PDT in the treatment of recalcitrant molluscum contagiosum.
J Drugs Dermatol 2004; 3: 187-90.
262. Watanabe D, Kawamura C, Masuda Y, et al. Successful treatment of
toenail onychomycosis with photodynamic therapy. Arch Dermatol
2008; 144: 19-21.
263. Morton CA, Whitehurst C, Moseley H, et al. Development of an alterna-
tive light source to lasers for photodynamic therapy: clinical evaluation
in the treatment of pre-malignant non-melanoma skin cancer. Lasers
Med Sci 1995; 10: 165-71.
264. Fijan S, Honigsmann H, Ortel B. Photodynamic therapy of epithelial
skin tumors with delta-aminolaevulinic acid and desferrioxamine. Br J
Dermatol 1995; 133: 282-8.
265. Wennberg AM, Lindholm LE, Alpsten M, Larkö O. Treatment of super-
fi cial basal cell carcinomas using topically applied delta-aminolaevulinic
acid and a fi ltered xenon lamp. Arch Dermatol Res 1996; 288: 561-4.
266. Haller JC, Cairnduff F, Slack G, et al. Routine double treatments of
superfi cial basal cell carcinomas using aminolaevulinic acid-based pho-
todynamic therapy. Br J Dermatol 2000; 143: 1270-5.
267. Soler AM, Angell-Petersen E, Warloe T, et al. Photodynamic therapy of
superfi cial basal cell carcinoma with 5-aminolevulinic acid with dimeth-
ylsulfoxide and ethylediaminetetraacetic acid: a comparison of two light
sources. J Photochen Photobiol 2000; 71: 724-9.
268. Surrenti T, De Angelis L, Di Cesare A, Fargnoli MC, Peris K. Effi cacy of
photodynamic therapy with methylaminolevulinate in the treatment of
superfi cial and nodular basal cell carcinoma: an open-label trial. Eur J
Dermatol 2007; 17: 412-15.
269. Fantini F, Greco A, Del Giovane D, et al. Photodynamic therapy for
basal cell carcinoma: clinical and pathological determinants of response.
J Eur Acad Dermatol Venereol 2011; 25: 896-901.
